19:51 GMT +319 September 2019
Listen Live
    Pharmaceutical industry

    Israel's Teva, Russia's Nanolek to Locate Pharmaceutical Production in Russia

    © Flickr / Chris Potter
    World
    Get short URL
    294
    Subscribe

    One of the world’s biggest pharmaceutical companies Teva and Russia’s Nanolek agreed to relocate production of sterile injection drugs to Russia, Nanolek said in a statement.

    JERUSALEM (Sputnik) — The industrial cooperation will start with the localization of the manufacturing of glatiramer acetate used to treat multiple sclerosis.

    "The aims of the partnership include producing sterile injection drugs on the basis of a biopharmaceutical plant of the Nanolek company, creating additional workplaces, training specialists, transfer of technologies including final quality inspection, transfer of intellectual property rights and attraction of investments," the statement said.

    It noted that pharmaceutical substances produced at Israeli plants would be used for producing medicines in Russia.

    Nanolek added that the production cycle would be completed in the fourth quarter of 2018.

    Related:

    US Pharmaceutical Companies to Pay $67Mln Over False Cancer Drug Claims
    Explosion at India’s Pharmaceutical Factory Kills Six
    Saudi-Led Coalition Airstrike Hits Pharmaceutical Factory in Yemen
    Tags:
    pharmaceutics, Israel, Russia
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik